Phospho lats1 s909

Manufactured by Cell Signaling Technology

Sourced in United States

Phospho-LATS1 S909 is a lab equipment product from Cell Signaling Technology. It is an antibody that detects endogenous levels of LATS1 protein when phosphorylated at serine 909.

Automatically generated - may contain errors

Lab products found in correlation

Lats1, by Cell Signaling Technology (2 mentions) Phospho akt t308, by Cell Signaling Technology (1 mentions) α tubulin, by Novus Biologicals (1 mentions) Gapdh, by Novus Biologicals (1 mentions) β actin, by Novus Biologicals (1 mentions) Cyr61, by Cell Signaling Technology (1 mentions) Phospho gsk3β s9, by Cell Signaling Technology (1 mentions) Antibody against e cadherin, by BD (1 mentions) Cleaved caspase 3, by Cell Signaling Technology (1 mentions) N ethylmaleimide nem, by Merck Group (1 mentions) Cycloheximide (chx), by Merck Group (1 mentions) Tamoxifen, by Merck Group (1 mentions) Mg132, by Merck Group (1 mentions) Matrigel, by Merck Group (1 mentions) 4 hydroxytamoxifen, by Merck Group (1 mentions) Phospho lats1, by Cell Signaling Technology (1 mentions) Imidazole, by Carl Roth (1 mentions) Mib2 antibody, by Fortis Life Sciences (1 mentions) D maltose, by Merck Group (1 mentions) Gapdh, by Cell Signaling Technology (1 mentions)

Spelling variants of this product

LATS1 (76 citations) Phospho-LATS1 (12 citations)

2 protocols using phospho lats1 s909

Comprehensive Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Cells were lysed in SDS lysis buffer (240 mM Tris-acetate, 1% SDS, 1% glycerol, 5 mM EDTA pH 8.0) with DTT, protease inhibitors, and a cocktail of phosphatase inhibitors. Antibody against vimentin, and MCP-1 were purchased from Abcam (Cambridge, MA, USA). Antibodies detecting CD44 and phospho-YAP S127 were purchased from GeneTex, Inc. (Irvine, CA, USA). Antibodies against YAP, phospho-MST1/MST2 T183/T180, MST1, phospho-LATS1 S909, LATS1, CYR61, CTGF, phospho–AKT T308, AKT, and phospho–GSK3β S9, phospho-ERK1/2, ERK1/2 were purchased from Cell Signaling Technology (Danvers, MA, USA). The β-actin, GAPDH, and α -tubulin antibodies were purchased from Novus Biologicals (Littleton, CO, USA). Antibody against E-cadherin was purchased from BD (Franklin Lakes, NJ, USA).

Lai C.J., Lin C.Y., Liao W.Y., Hour T.C., Wang H.D, & Chuu C.P. (2019). CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. Cells, 8(4), 295.

+ Open protocol

+ Expand

Reagents for Protein Interaction Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols

Tamoxifen (catalog #T5648), 4-hydroxy Tamoxifen (catalog #H7904), MG132 (catalog #M8699), N-ethylmaleimide (NEM) (catalog #E3876), cycloheximide (catalog #239763), reduced L-glutathione (catalog #G4251) and D-maltose (catalog #M9171) were purchased from Sigma-Aldrich. Antibodies directed against ERG (catalog #ab92513), CD31 (catalog #ab7388), FAT1 (catalog #ab109202), FAT4 (catalog #ab130076) were from Abcam. Isolectin GS-IB4 (catalog #I21413/I32450) was from Life Technologies GmbH. Antibodies directed against HA (catalog #H6533), Flag M2 (catalog #A8592) were from Sigma-Aldrich. Antibodies directed against YAP/TAZ (catalog #8418), YAP (catalog #4912), Lamin A/C (catalog #2032), GAPDH (catalog #2118), LATS1 (catalog #3477), phospho-LATS1 (S909) (catalog #9157), phospho-LATS1 (catalog #1079) (catalog #8654), phospho-MST1 (T183) (catalog #3681) phospho-MOB1 (T35) (catalog #8699) Ubiquitin (catalog #3936S), Cleaved Caspase-3 (catalog #9664), CYLD (catalog #8462) were obtained from Cell Signaling. The MIB2 antibody (catalog #A301-414A) was from Bethyl Laboratories, and Matrigel (catalog #356231) was purchased from Merck. Isopropyl-β-D-1-thiogalactopyranosid (IPTG) (catalog #CN08.2) and imidazole (catalog #X998.3) were from Carl Roth GmbH.

Li R., Shao J., Jin Y.J., Kawase H., Ong Y.T., Troidl K., Quan Q., Wang L., Bonnavion R., Wietelmann A., Helmbacher F., Potente M., Graumann J., Wettschureck N, & Offermanns S. (2023). Endothelial FAT1 inhibits angiogenesis by controlling YAP/TAZ protein degradation via E3 ligase MIB2. Nature Communications, 14, 1980.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!